About Our Center
Congratulations to the Emory ALS Center for performing the final stem cell transplant in the "Phase II, Open-label, Dose Escalation and Safety Study of Human Spinal Cord derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis.” This is a major milestone for this trial (sponsored by Neuralstem, Inc.) as well as for the progress of testing stem cell therapeutics for ALS. We have now completed 18 surgeries in 15 patients during Phase I, and another 18 surgeries in 15 patients in Phase II, with the final 3 patients in each Phase receiving transplants into the lower (lumbar) spinal cord as well as the upper (cervical) spinal cord. The final results from Phase II trial will not be available for some months. Information on additional stem cell transplant research will be posted on the web site as soon as it is available.
The Emory ALS Center, led by Dr. Jonathan Glass, is one of the largest clinical centers for ALS in the United States. The Center provides true multidisciplinary care for patients and families with ALS and related disorders. Our team of neurologists, neurosurgeons, nurses, therapists, and dieticians care for both the physical and emotional needs of our patients and their families. The focus of our patient model is on independence and quality of life through state-of-the-art intervention.
Emory ALS Center physician-scientists continue to perform groundbreaking research, including developing surgical methods for delivery of therapeutics to the spinal cord. Our researchers search tirelessly for a cure for this devastating disease, focusing on basic mechanisms of motor neuron degeneration, genetics of ALS, and new experimental treatments. Read more about our center here.